The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harmar, A. J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J. R., Rawlings, S. R., Robberecht, P., Said, S. I., Sreedharan, S. P., et al. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01360-7 · Cited by 765
Reubi, J., Waser, B., Schaer, J.-C., & Laissue, J. A. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100541 · Cited by 657
Self-citationLOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Lameris, J. S., Bakker, W. H., Koper, J. W., Ausema, L., Reubi, J. C., & Lamberts, S. W. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91258-0 · Cited by 625
Self-citationGastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
Markwalder, R. V., & Reubi, J. C. (1999) · PubMed · Cited by 506
Self-citation[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P., Konijnenberg, M. W., Srinivasan, A., Erion, J. L., Schmidt, M. A., Bugaj, J. L., de Jong, M., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100574 · Cited by 471
Gibril, F., Reynolds, J. C., Doppman, J. L., Chen, C. C., Venzon, D. J., Termanini, B., Weber, H. C., Stewart, C. A., & Jensen, R. T. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00005 · Cited by 440
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi, J. C., Schaer, J., & Waser, B. (1997) · PubMed · Cited by 349
Self-citationYttrium-90-labelled somatostatin-analogue for cancer treatment
Otte, A., Mueller-Brand, J., Dellas, S., Nitzsche, E., Herrmann, R., & Maecke, H. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78355-0 · Cited by 335
Wank, S. A. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.5.g628 · Cited by 323
Reubi, J. C., Läderach, U., Waser, B., Gebbers, J.-O., Robberecht, P., & Laissue, J. A. (2000) · PubMed · Cited by 287
Self-citation
Cited by
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
Self-citationOpportunities in somatostatin research: biological, chemical and therapeutic aspects
Weckbecker, G., Lewis, I., Albert, R., Schmid, H. A., Hoyer, D., & Bruns, C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1255 · Cited by 559
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
Korner, M., Stockli, M., Waser, B., & Reubi, J. C. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.038679 · Cited by 477
“Endocrine tumors Pheochromocytomas 12/20 (60) 3,970 6 1,002 Paragangliomas 5/18 (28) 1,353 6 601 Medullary thyroid carcinomas 5/18 (28) 1,326 6 264 Adrenal cortical adenomas 0/7 (0) Parathyroid carcinomas 0/4 (0) Pituitary adenomas 0/38 (0) Tumors of nervous system Meningiomas 7/20 (35) 989 6 271 Astrocytomas 4/16 (25…”
BackgroundMethodInfluentialSelf-citationKayani, I., Bomanji, J. B., Groves, A., Conway, G., Gacinovic, S., Win, T., Dickson, J., Caplin, M., & Ell, P. J. (2008) · Cancer · doi:10.1002/cncr.23469 · Cited by 477
Cholecystokinin and Gastrin Receptors
Dufresne, M., Seva, C., & Fourmy, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00014.2005 · Cited by 476
Virgolini, I., Ambrosini, V., Bomanji, J. B., Baum, R. P., Fanti, S., Gabriel, M., Papathanasiou, N. D., Pepe, G., Oyen, W., De Cristoforo, C., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1512-3 · Cited by 442
Imaging of Neuroendocrine Tumors
Rufini, V., Calcagni, M. L., & Baum, R. P. (2006) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2006.03.007 · Cited by 376
Selenocysteine in proteins—properties and biotechnological use
Johansson, L., Gafvelin, G., & Arnér, E. S. J. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.05.010 · Cited by 352
68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
Poeppel, T. D., Binse, I., Petersenn, S., Lahner, H., Schott, M., Antoch, G., Brandau, W., Bockisch, A., & Boy, C. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.091165 · Cited by 346
Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer
Fani, M., Maecke, H. R., & Okarvi, S. M. (2012) · Theranostics · doi:10.7150/thno.4024 · Cited by 333
Imaging of Neuroendocrine Tumors
Heller, M. T., & Shah, A. B. (2011) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2011.02.011 · Cited by 329
Peptide-Based Probes for Targeted Molecular Imaging
Lee, S., Xie, J., & Chen, X. (2010) · Biochemistry · doi:10.1021/bi901135x · Cited by 310
Rationale for the use of somatostatin analogs as antitumor agents
Susini, C., & Buscail, L. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl105 · Cited by 304
Peptide-Based Probes for Cancer Imaging
Reubi, J. C., & Maecke, H. R. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.053041 · Cited by 286
Self-citationGlucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas
Christ, E., Wild, D., Forrer, F., Brändle, M., Sahli, R., Clerici, T., Gloor, B., Martius, F., Maecke, H., & Reubi, J. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1082 · Cited by 268
Self-citationAmbrosini, V., Tomassetti, P., Castellucci, P., Campana, D., Montini, G., Rubello, D., Nanni, C., Rizzello, A., Franchi, R., & Fanti, S. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0769-2 · Cited by 266
Hofland, J., Falconi, M., Christ, E., Castaño, J. P., Faggiano, A., Lamarca, A., Perren, A., Petrucci, S., Prasad, V., Ruszniewski, P., et al. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13318 · Cited by 259
Peptide Receptor Radionuclide Therapy: An Overview
Dash, A., Chakraborty, S., Pillai, M. R. A., & Knapp, F. F. (. (2015) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1741 · Cited by 128
“150,151 GLP-1 is strongly overexpressed in greater than 90% of insulinomas with a density reported to be more than twice that of SSTR 2 .”
Antwi, K., Fani, M., Heye, T., Nicolas, G., Rottenburger, C., Kaul, F., Merkle, E., Zech, C. J., Boll, D., Vogt, D. R., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4101-5 · Cited by 124
Glucagon-Like-Peptide-1 Receptor Expression in Normal and Diseased Human Thyroid and Pancreas
Waser, B., Blank, A., Karamitopoulou, E., Perren, A., & Reubi, J. C. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.113 · Cited by 119
Self-citationInnovative imaging of insulinoma: the end of sampling? A review
Christ, E., Antwi, K., Fani, M., & Wild, D. (2020) · Endocrine-Related Cancer · doi:10.1530/erc-19-0476 · Cited by 78
“Importantly, an extensive evaluation concerning the potential of the GLP-1R for targeted tumor imaging confirmed a nearly 100% incidence of GLP-1R expression on benign insulinomas with an about 5x higher density of GLP-1R on insulinomas compared to normal beta cells (Reubi & Waser 2003).”
BackgroundMethodInfluentialShi, M., Jakobsson, V., Greifenstein, L., Khong, P.-L., Chen, X., Baum, R. P., & Zhang, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1034315 · Cited by 68
Radiolabeled somatostatin analogs-a continuously evolving class of radiopharmaceuticals.
Fani, M., Mansi, R., Nicolas, G. P., & Wild, D. (2022) · Cancers · doi:10.3390/cancers14051172 · Cited by 56
Pach, D., Sowa-Staszczak, A., Jabrocka-Hybel, A., Stefańska, A., Tomaszuk, M., Mikołajczak, R., Janota, B., Trofimiuk-Müldner, M., Przybylik-Mazurek, E., & Hubalewska-Dydejczyk, A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/384508 · Cited by 25
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
Boss, M., Bos, D., Frielink, C., Sandker, G., Bronkhorst, P., van Lith, S. A. M., Brom, M., Buitinga, M., & Gotthardt, M. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.238998 · Cited by 15
Metadata
- Authors
- Reubi, J. C., & Waser, B.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2003-04-18
- Volume
- 30
- Issue
- 5
- Pages
- 781-793
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2080916065
- Cited by
- 592
- References
- 23
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.